Interestingly, at the cut-off value of ≥20% of tumour cells with positive staining, 41.3% of the cases were EGFRvIII, and 34%, 44%, 15%, and 56% were positive for wtEGFR, HER2, HER3, and HER4, respectively. The gene discussed is ERBB4; the disease is neoplasm.